02-32157. Pulmonary-Allergy Drugs Advisory Committee; Cancellation

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is canceling the meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for December 20, 2002. This meeting was announced in the Federal Register of November 13, 2002 (67 FR 68878).

FOR FURTHER INFORMATION CONTACT:

Kimberly L. Topper, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX [phone], or e-mail: [e-mail], or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12545.

Dated: December 16, 2002.

Linda Arey Skladany,

Associate Commissioner for External Relations.